Skip to main navigation
Skip to search
Skip to main content
Pure University (For Demo Only) Home
Help & FAQ
English
中文
Home
Profiles
Research units
Research output
Equipment
Datasets
Activities
Prizes
Impacts
Projects
Press/Media
Search by expertise, name or affiliation
Edoxaban versus warfarin in patients with atrial fibrillation
ENGAGE AF-TIMI 48 Investigators
Nursing
Research output
:
Contribution to journal
›
Article
›
peer-review
4291
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Edoxaban versus warfarin in patients with atrial fibrillation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
8%
Atrial Fibrillation
100%
Bleeding
25%
Blood Clotting Factor 10a Inhibitor
8%
Edoxaban
100%
Warfarin
100%
Keyphrases
Antithrombotic Effect
8%
Daiichi
8%
Direct Oral
8%
ENGAGE AF-TIMI 48
8%
Oral Factor Xa Inhibitors
8%
Pharma
8%